SCSong Chen

Song Chen

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Song Chen has a total of 146 co-authors. Here are the top co-authors by number of shared publications:

  • Weizhong Guo

    Guangzhou University of Chinese Medicine, Guangzhou 510405, China

    11 shared publications
  • Chunhui Lai

    Science and Technology Innovation Center, Guangzhou University of Chinese Medicine, Guangzhou 510405, China

    7 shared publications
  • Wei Lu

    Sino-French Collaborative Laboratory, Tropical Medicine Institute, Guangzhou University of Chinese Medicine, Guangzhou, China

    7 shared publications
  • Huanhuan Luo

    School of Basic Medicine, Guangzhou University of Chinese Medicine, Guangzhou, China

    6 shared publications
  • Linchun Fu

    Sino-French Collaborative Laboratory, Tropical Medicine Institute, Guangzhou University of Chinese Medicine, Guangzhou, China

    6 shared publications
  • Jean-Marie Andrieu

    Institut de Recherche sur les Vaccins et l'Immunologie des Cancers et du Sida, Université Paris Descartes/Institut de Recherche pour le Développement, Paris, France

    5 shared publications

Latest Publications

  • Palladium-Catalyzed Fast Decaging of Propargyloxycarbonyl (Proc)-Caged Guanidines

    by Jing Zhang, Lingling Xiang, Yunshi Liang, Yiting He, Yinjun Wang, Shu Zhang, Yunyao Li, Qin Tang, Song Chen, Hong Qiu

    The Pd-catalyzed decaging reaction enables spatiotemporal control of amine-containing biomolecules, but analogous methods for guanidino-containing substrates remain underdeveloped. Here, we report a new Pd-catalyzed decaging chemistry for guanidines, with a propargyloxycarbonyl (Proc) moiety as the caging group in the absence of a phosphine ligand. Compared to our previous allyloxycarbonyl (Alloc)-based approach and the classical amine decaging chemistry, this system achieves remarkably accelerated decaging kinetics and high efficiency for both aromatic and aliphatic guanidines. Mechanistic studies reveal that the adjacent nitrogen atoms of the guanidino group accelerate the decaging process, probably in a “self-liganded” manner. Further application of this strategy is highlighted by the Pd-triggered release of Proc-caged guanidinyl fluorophores within minutes in living cells.

  • Open Access

    Indirubin regulates M1/M2 polarization and inhibits ferroptosis in dextran sulfate sodium induced colitis and in cultured THP-1 cells

    by Yong-Xiang Huang, Jin-Ru Zhang, Shi-Hua Fu, Zhe Liu, Hui-Jun Zhong, Qing-Yang Zhong, Yin-Di Luo, Ying-Jie Hu, Hai-Peng Zhu, Bin Wen, et al.

    Macrophages play a critical role in the pathogenesis of ulcerative colitis (UC). Indirubin (IDR), a natural ligand of the aryl hydrocarbon receptor (AhR), has been shown to ameliorate DSS-induced colitis in our previous study (Liu Z et al.). To investigate whether IDR exerts its protective effects by regulating M1/M2 polarization and inhibiting ferroptosis in macrophages. Immunohistochemistry staining targeting CD206 and F4/80 was performed to evaluate the effect of IDR on the polarization of M1/M2 macrophages in colitis. Subsequently, the effects of IDR on the M1- or M2-polarization of THP-1-derived macrophages were investigated. Furthermore, the effects of IDR on ferroptosis in the colon tissue of mice and on RSL3-induced ferroptosis in THP-1-derived macrophages were assessed. The results were verified in mouse peritoneal macrophages. In addition to reducing the infiltrated macrophages, IDR treatment preserved CD206+ macrophages in DSS-induced colitis. Using cultured THP-1 cells, we demonstrated that IDR inhibited M1 polarization and prompted M2 polarization. Furthermore, we showed that IDR treatment decreased levels of 4-HNE while increasing GPX4 and NRF2 in DSS-induced colitis and THP-1 cells. IDR treatments also reduced cellular reactive oxygen species (ROS) and iron content, and mitigated RSL3-induced ferroptosis in THP-1-derived macrophages. Similarly, IDR augmented M2-polarization and alleviated ferroptosis in peritoneal macrophages. IDR skews the polarization of macrophages from M1 to M2. Furthermore, it inhibits ferroptosis in both mice and THP-1-derived macrophages. These mechanisms may contribute to the therapeutic effects of IDR in the treatment of UC.


  • Open Access

    Comparison of Efavirenz and Dolutegravir on Gut Microbiome and Gut Barrier Functions

    by Yong-Xiang Huang, Qin Tang, Shi-Hua Fu, Hui-Jun Zhong, Zhe Liu, Qing-Yang Zhong, Yan-Hao Wang, Yin-Di Luo, Xue-Ying Li, Song Chen, et al.

    Dolutegravir (DTG) is increasingly replacing efavirenz (EFV) as the recommended first-line antiretroviral therapy (cART) component due to its superior tolerance. However, both EFV-based and DTG-based cART regimens are associated with metabolic and neuropsychiatric disorders through mechanisms that remain poorly understood. In this study, the abundance of Lactobacillus was significantly reduced, along with elevated soluble CD14 levels, in HIV-1-infected individuals receiving EFV-based cART compared to those on DTG-based cART. Additionally, EFV treatment in mice resulted in the destruction of intestinal crypts, loss of goblet cells, decreased expression of intestinal ZO-1, and more severe damage to gut barrier integrity compared to the DTG and normal control groups. Furthermore, we identified a significant reduction in Lactobacillus in EFV-treated mice. Our results suggest that EFV and DTG may directly lead to gut dysbiosis and compromised gut barrier integrity, which could be targeted to prevent the side effects associated with EFV and DTG.


  • Open Access

    Aquaporin-3 promotes proliferation and inflammation in hepatocellular carcinoma

    by Yao Wang, Yalan Wu, Xueying Li, Weiwei Song, Fengling Zheng, Xiaoying Mo, Yi Luo, Yun Li, Song Chen, Huanhuan Luo


  • Open Access

    Intestinal microflora promotes Th2-mediated immunity through NLRP3 in damp and heat environments

    by Yi Luo, Xinhua Huang, Haiying Hu, Yao Wang, Xiangrong Feng, Song Chen, Huanhuan Luo

    Background: With the worsening of the greenhouse effect, the correlation between the damp-heat environment (DH) and the incidence of various diseases has gained increasing attention. Previous studies have demonstrated that DH can lead to intestinal disorders, enteritis, and an up-regulation of NOD-like receptor protein 3 (NLRP3). However, the mechanism of NLRP3 in this process remains unclear.Methods: We established a DH animal model to observe the impact of a high temperature and humidity environment on the mice. We sequenced the 16S rRNA of mouse feces, and the RNA transcriptome of intestinal tissue, as well as the levels of cytokines including interferon (IFN)-γ and interleukin (IL)-4 in serum.Results: Our results indicate that the intestinal macrophage infiltration and the expression of inflammatory genes were increased in mice challenged with DH for 14 days, while the M2 macrophages were decreased in Nlrp3-/- mice. The alpha diversity of intestinal bacteria in Nlrp3-/- mice was significantly higher than that in control mice, including an up-regulation of the Firmicutes/Bacteroidetes ratio. Transcriptomic analysis revealed 307 differentially expressed genes were decreased in Nlrp3-/- mice compared with control mice, which was related to humoral immune response, complement activation, phagocytic recognition, malaria and inflammatory bowel disease. The ratio of IFN-γ/IL-4 was decreased in control mice but increased in Nlrp3-/- mice.Conclusions: Our study found that the inflammation induced by DH promotes Th2-mediated immunity via NLRP3, which is closely related to the disruption of intestinal flora.


  • Open Access

    Gut microbiota associated with appetite suppression in high-temperature and high-humidity environments

    by Yalan Wu, Xiangrong Feng, Mengjun Li, Zongren Hu, Yuhua Zheng, Song Chen, Huanhuan Luo


  • Open Access

    Distinct microbiome of tongue coating and gut in type 2 diabetes with yellow tongue coating

    by Yao Wang, Jiqing Li, Haiying Hu, Yalan Wu, Song Chen, Xiangrong Feng, Ting Wang, Yinrong Wang, Su Wu, Huanhuan Luo


  • Open Access

    Alteration in Gut Microbiome and Intestinal Barrier Function caused by Efavirenz versus Dolutegravir Treatments in Mice

    by Qin Tang, Hai-En Pan, Zhe Liu, Zhou Deng, Qing-Yang Zhong, Huan-Huan Cao, Jun-Yan Ye, Jin Li, Xue-Ying Li, Hai-Peng Zhu, et al.

    Dolutegravir (DTG) is replacing efavirenz (EFV) as first-line antiretroviral therapy because of its better tolerance. However, DTG cause similar, but milder, gastrointestinal and neurological side effects as EFV does. We speculated that impaired gut barrier function contributes to their side effects. For this purpose, the mice were intragastrically administered EFV, DTG, or vehicle for 60 consecutive days. The plasma levels of FITC-dextran were determined to evaluate gut barrier integrity. Colonic contents were collected for 16S rRNA sequencing. Adipose, liver, ileum, and colon tissues were collected for pathological examination, and intestinal zona occludens-1 (ZO-1) immunofluorescence staining and goblet cell staining were performed. We found that EFV significantly retarded body weight gain, decreased glucose uptake, and caused lipodystrophy and hepatocyte necrosis. EFV also decreased species richness of gut microbiota, increased Verrucomicrobia and Proteobacteria, and decreased Patescibacteria and Cyanobacteria. Moreover, it caused crypt damage, goblet cell loss, reduced ZO-1 expression, impaired gut barrier function, and suppressed expressions of Pdha1 and Ndufv1. Interestingly, DTG impaired barrier function similar to EFV, but the impairment was milder. DTC also inhibited MPC1, MPC2, and Pdha1 expression. Our results suggest a link between abnormal energy metabolism, impaired gut barrier integrity and side effects of EFV and DTG.

  • Open Access

    Transcriptomic analysis reveals the regulatory mechanism underlying the indirubin-mediated amelioration of dextran sulfate sodium-induced colitis in mice

    by Zhe Liu, Jin-Ru Zhang, Yong-Xiang Huang, Xue-Ying Li, Hai-Peng Zhu, Rui-Yi Yang, Song Chen

    Aryl hydrocarbon receptor (AhR) agonists are potential therapeutic agents for ulcerative colitis (UC). Indirubin (IDR), which is a natural AhR ligand approved for leukemia treatment, ameliorates dextran sulfate sodium (DSS)-induced colitis in mice. However, the therapeutic mechanisms of IDR are unknown, limiting its application. This study explores the therapeutic mechanisms of IDR in DSS-induced colitis using transcriptomic analysis. Male BALB/c mice were categorized to six groups: normal, DSS model (2% DSS), IDR treatment (10, 20 and 40 mg/kg), and sulfasalazine (520 mg/kg) groups. The drugs were intragastrically administered for 7 consecutive days. The disease activity index (DAI) was recorded. After euthanasia, the colon length was measured, and histopathological examination, immunohistochemistry staining using F4/80, and colonic transcriptomic analysis were conducted. Quantitative reverse transcription-polymerase chain reaction (qRT-PCR) and western blotting (WB) were conducted to verify our findings. Compared with DSS, IDR treatment decreased the DAI score by 64.9% and increased colon length by 26.2%. Moreover, it alleviated mucosal injury and reduced macrophage infiltration. Transcriptomic analysis identified several downregulated genes (Igkvs and Nlrp3), as well as Nlrp3/Il1β and hemoglobin gene networks, after IDR treatment. The abundances of NF-κB p65, NLRP3, IL-1β, and HBA decreased by 69.1, 59.4, 81.1, and 83.0% respectively, after IDR treatment. Apart from the well-documented NF-κB signalling pathway, IL-17A, and NLRP3-IL-1β, the suppression of haemoglobin-induced lipid peroxidation could be a previously unknown mechanism of IDR. Our study can help improve its application for UC treatment.